Islet cell autoantibodies in African patients with Type 1 and Type 2 diabetes in Dar es Salaam Tanzania: A cross sectional study

Journal of Autoimmune Diseases

Volumn 4, Issue , 2007, Pages

  Lutale, J J K ^a,b   Thordarson, H ^d   Holm, P I ^d   Eide, G E ^a,d   Vetvik, K ^a,c  

^a UNIVERSITY OF BERGEN   (Norway)

^b MUHIMBILI UNIVERSITY OF HEALTH AND ALLIED SCIENCES   (Tanzania)

^c Haraldsplass Hospital   (Norway)

^d HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; C PEPTIDE; GLUCOSE; GLUTAMATE DECARBOXYLASE ANTIBODY; HEMOGLOBIN A1C; INSULINOMA ANTIGEN 2 AUTOANTIBODY; PANCREAS ISLET CELL ANTIBODY; UNCLASSIFIED DRUG;

ADULT; AFRICA; ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; AUTOIMMUNE DISEASE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; FAMILY HISTORY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; IMMUNOASSAY; INSULIN DEPENDENT DIABETES MELLITUS; LIGAND BINDING; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET CELL; PREVALENCE; RADIOASSAY; STATISTICAL SIGNIFICANCE;

EID: 37349065491     PISSN: None     EISSN: 17402557     Source Type: Journal    
DOI: 10.1186/1740-2557-4-4     Document Type: Article

References (36)

1. The discovery of type 1 diabetes. EA Gale, Diabetes 2001 50 217 226 10.2337/diabetes.50.2.217 11272129
2. Predictive value of islet cell and insulin autoantibodies for Type 1 (insulin-dependent) diabetes mellitus in a population-based study of newly-diagnosed diabetic and matched control children. M Landin-Olsson JP Palmer Lernmarks L Blom G Sundkvist L Nystrãm G Dahlquist, Diabetologia 1992 V35 1068 1073 10.1007/BF02221683
3. Autoimmune type 1 diabetes: resolved and unresolved issues. AL Notkins A Lernmark, J Clin Invest 2001 108 1247 1252 11696564 10.1172/JCI200114257
4. High prevalence of GAD65 (and IA-2) antibodies in Japanese IDDM patients by a new immunoprecipitation assay based on recombinant human GAD65. H Akamine I Komiya T Shimabukuro T Asawa H Tanaka N Yagi T Taira K Nagata K Arakaki T Wakugami N Takasu MJ Powell J Furmaniak BR Smith, Diabet Med 1997 14 778 784 10.1002/(SICI)1096-9136(199709)14:9<778::AID-DIA461>3.0.CO;2-7 9300229
5. Is Type 1 diabetes in the Japanese population the same as among Caucasians? E Kawasaki K Eguchi, Ann N Y Acad Sci 2004 1037 96 103 10.1196/annals.1337.014 15699499
6. The prevalence of islet-cell antibodies and complement-fixing islet-cell antibodies in Japanese diabetics. T Kobayashi S Sawano T Itoh T Sugimoto T Tanaka S Suwa, Endocrinol Jpn 1981 28 429 433 6763893
7. Prevalence of ICA and GAD antibodies at initial presentation of type 1 diabetes mellitus in Singapore children. YS Lee WY Ng AC Thai KF Lui KY Loke, J Pediatr Endocrinol Metab 2001 14 767 772 11453527
8. Low prevalence of autoimmune diabetes markers in a mixed ethnic population of Singaporean diabetics. AL Todd WY Ng KF Lui AC Thai, Intern Med J 2004 34 24 30 10.1111/j.1444-0903.2004.00482.x 14748910
9. Islet cell antibodies are not specifically associated with insulin-dependent diabetes in Tanzanian Africans. DG McLarty I Athaide GF Bottazzo AM Swai KG Alberti, Diabetes Res Clin Pract 1990 9 219 224 10.1016/0168-8227(90)90048-X 2226121
10. Islet cell antibodies and diabetes in Nigerians. JM Oli GF Bottazzo D Doniach, Trop Geogr Med 1981 33 161 164 7025394
11. Islet cell antibodies and other autoantibodies in South African blacks and Indians with insulin dependent diabetes mellitus (IDDM). MA Omar Bottazzo G, Asmal AC, Horm Metab Res 1986 18 126 128 3516822
12. The frequency of islet cell surface antibodies in newly diagnosed diabetics from Ethiopia. WH Peters FT Lester KD Kohnert W Hildmann, Exp Clin Endocrinol 1986 87 326 332 3536536
13. Distribution of autoantibodies to glutamic acid decarboxylase across the spectrum of diabetes mellitus seen in South Africa. VR Panz WJ Kalk M Zouvanis BI Joffe, Diabet Med 2000 17 524 527 10.1046/j.1464-5491.2000.00324.x 10972582
14. Islet cell and other organ-specific antibodies in U.S. Caucasians and Blacks with insulin-dependent diabetes mellitus. M Neufeld NK Maclaren WJ Riley D Lezotte JV McLaughlin J Silverstein AL Rosenbloom, Diabetes 1980 29 589 592 10.2337/diabetes.29.8.589 7002675
15. Islet cell autoimmunity in white and black children and adolescents with IDDM. IM Libman M Pietropaolo M Trucco JS Dorman RE LaPorte D Becker, Diabetes Care 1998 21 1824 1827 10.2337/diacare.21.11.1824 9802728
16. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997 20 1183 1197 9203460
17. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. KG Alberti PZ Zimmet, Diabet Med 1998 15 539 553 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S 9686693
18. Autoantibodies in diabetes. C Pihoker LK Gilliam CS Hampe A Lernmark, Diabetes 2005 54 Suppl 2 S52 61 10.2337/diabetes.54.suppl_2.S52 16306341
19. UKPDS 25: autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes. UK Prospective Diabetes Study Group. R Turner I Stratton V Horton S Manley P Zimmet IR Mackay M Shattock GF Bottazzo R Holman, Lancet 1997 350 1288 1293 10.1016/S0140-6736(97)03062-6 9357409
20. Clinical summary report. Clinical performance of DCA 2000+ hemoglobin A1c system six-minute assay. CE Hiar, Bayer Diagnostic Division 1-7, April 1998
21. The Diabetes Research in Children Network (DirectNet) Study Group. Comparison of fingerstick hemoglobin A1c levels assayed by DCA2000 with the DCCT/EDIC central laboratory assay: results of a Diabetes Research in Children Network (DirectNet) Study. Pediatric Diabetes 2005 6 13 16 10.1111/j.1399-543X. 2005.00088.x 15787896
22. Diabetes Antibody Standardization Program: first assay proficiency evaluation. PJ Bingley E Bonifacio PW Mueller, Diabetes 2003 52 1128 1136 10.2337/diabetes.52.5.1128 12716742
23. Comparison of immunoassays for the detection of anti-GAD65 autoantibodies in patients with diabetes mellitus. A Pfutzner O Harzer T Kunt T Forst N Abdollahnia M Lobig H Krauss M Engelbach P Kann J Beyer, Clin Lab 2000 46 275 279 10853236
24. Comparative analysis of organ-specific autoantibodies and celiac disease - associated antibodies in type 1 diabetic patients, their first-degree relatives, and healthy control subjects. C Jaeger E Hatziagelaki R Petzoldt RG Bretzel, Diabetes Care 2001 24 27 32 10.2337/diacare.24.1.27 11194235
25. Insulin antibodies are associated with lipoatrophy but also with lipohypertrophy in children and adolescents with type 1 diabetes. K Raile V Noelle R Landgraf HP Schwarz, Exp Clin Endocrinol Diabetes 2001 109 393 396 10.1055/s-2001-18991 11748486
26. Influence of age on clinical and immunological characteristics of newly diagnosed type 1 diabetic patients. C Fajardo F Pinon E Carmona JM Sanchez-Cuenca JF Merino C Carles, Acta Diabetol 2001 38 31 36 10.1007/s005920170026 11487174
27. Autoantibodies to GAD and IA-2 in Saudi Arabian diabetic patients. LH Damanhouri JA Dromey MR Christie HA Nasrat MS Ardawi RA Robins I Todd, Diabet Med 2005 22 448 452 10.1111/j.1464-5491.2005.01438.x 15787671
28. Autoantibodies against IA2, GAD, and topoisomerase II in type 1 diabetic patients. MYS Yih-Hsin Chang Shi-Tzer Tsai and Michael S.Lan, Biochemical and Biophysical research communications 2004 320 802 809 10.1016/j.bbrc.2004.05.215
29. Prediction of IDDM in the general population: strategies based on combinations of autoantibody markers. PJ Bingley E Bonifacio AJ Williams S Genovese GF Bottazzo EA Gale, Diabetes 1997 46 1701 1710 10.2337/diabetes.46.11. 1701 9356015
30. Evaluation of the new ADA and WHO criteria for classification of diabetes mellitus in young adult people (15-34 yrs) in the Diabetes Incidence Study in Sweden (DISS). H Borg HJ Arnqvist E Bjork J Bolinder JW Eriksson L Nystrom JO Jeppsson G Sundkvist, Diabetologia 2003 46 173 181 10.1007/s00125-002-1021-4 12627315
31. High frequency of persisting or increasing islet-specific autoantibody levels after diagnosis of type 1 diabetes presenting before 40 years of age. The Belgian Diabetes Registry. K Decochez J Tits JL Coolens L Van Gaal G Krzentowski F Winnock E Anckaert I Weets DG Pipeleers FK Gorus, Diabetes Care 2000 23 838 844 10.2337/diacare.23.6.838 10841006
32. Significance of IA-2 antibody in Japanese type 1 diabetes: its association with GAD antibody. T Ota T Takamura Y Nagai Y Bando R Usuda, Diabetes Res Clin Pract 2005 67 63 69 10.1016/j.diabres.2004.05.004 15620435
33. Familial risk of type I diabetes in European children. The Eurodiab Ace Study Group and The Eurodiab Ace Substudy 2 Study Group. Diabetologia 1998 41 1151 1156 10.1007/s001250051044 9794100
34. Family history and risk of insulin-dependent diabetes mellitus: a population-based case-control study. E Altobelli F Chiarelli M Valenti A Verrotti A Blasetti F Di Orio, Acta Diabetol 1998 35 57 60 10.1007/s005920050102 9625291
35. The Role of HLA Class I Gene Variation in Autoimmune Diabetes. C Sia W Michael, Rev Diabet Stud 2005 2 97 109 17491685 10.1900/RDS.2005.2.97
36. Autoantibodies associated with Type I diabetes mellitus persist after diagnosis in children. K Savola E Sabbah P Kulmala P Vahasalo J Ilonen M Knip, Diabetologia 1998 41 1293 1297 10.1007/s001250051067 9833935